Ann: ResAppDx to be Formally Evaluated by Doctors Without Borders, page-22

Not sure what marketing aspect. The real money will be made when we start getting regulatory approvals which is dependant on clinical studies coming back with good results.

These humanitarian orginisations will probably take ages to sign up to anything that brings in revenue and may not be that much anyway. It's more of a charitable part of the RAP story. Not sure what the trading halt was all about but hey it gets everyone excited and people on this forum will make a huge deal of it as usual.